Abdominal 0 9 0 9 O
and/or 10 16 10 16 O
pelvic 17 23 17 23 O
lymph 24 29 24 29 O
nodes 30 35 30 35 O
measuring 36 45 36 45 O
2 46 47 46 47 B-upper_bound
cm 48 50 48 50 I-upper_bound
or 51 53 51 53 O
less 54 58 54 58 O
in 59 61 59 61 O
short 62 67 62 67 O
axis 68 72 68 72 O
diameter 73 81 73 81 O

Age 0 3 82 85 B-age
≥ 4 5 86 87 O
18 6 8 88 90 B-lower_bound
years 9 14 91 96 I-lower_bound

Any 0 3 97 100 O
chronic 4 11 101 108 O
medical 12 19 109 116 O
condition 20 29 117 126 O
requiring 30 39 127 136 O
a 40 41 137 138 O
higher 42 48 139 145 O
dose 49 53 146 150 O
of 54 56 151 153 O
corticosteroid 57 71 154 168 B-treatment
than 72 76 169 173 O
equivalent 77 87 174 184 O
of 88 90 185 187 O
5 91 92 188 189 B-lower_bound
mg 93 95 190 192 I-lower_bound
prednisone 96 106 193 203 B-treatment
/ 106 107 203 204 O
prednisolone 107 119 204 216 B-treatment
once 120 124 217 221 O
daily 125 130 222 227 O

Biochemically 0 13 228 241 B-cancer
recurrent 14 23 242 251 I-cancer
prostate 24 32 252 260 I-cancer
cancer 33 39 261 267 I-cancer
with 40 44 268 272 O
PSA 45 48 273 276 B-clinical_variable
doubling 49 57 277 285 I-clinical_variable
time 58 62 286 290 I-clinical_variable
≤ 63 64 291 292 O
9 65 66 293 294 B-upper_bound
months 67 73 295 301 I-upper_bound
at 74 76 302 304 O
the 77 80 305 308 O
time 81 85 309 313 O
of 86 88 314 316 O
study 89 94 317 322 O
entry 95 100 323 328 O

Estimated 0 9 329 338 O
creatinine 10 20 339 349 B-clinical_variable
clearance 21 30 350 359 I-clinical_variable
> 31 32 360 361 O
45 33 35 362 364 B-lower_bound
ml 36 38 365 367 I-lower_bound
/ 38 39 367 368 I-lower_bound
min 39 42 368 371 I-lower_bound
using 43 48 372 377 O
Cockroft 49 57 378 386 O
- 57 58 386 387 O
Gault 58 63 387 392 O
equation 64 72 393 401 O

Hemoglobin 0 10 402 412 B-clinical_variable
≥ 11 12 413 414 O
9.0 13 16 415 418 B-lower_bound
g 17 18 419 420 I-lower_bound
/ 18 19 420 421 I-lower_bound
dL 19 21 421 423 I-lower_bound
independent 22 33 424 435 O
of 34 36 436 438 O
transfusion 37 48 439 450 O
and/or 49 55 451 457 O
growth 56 62 458 464 O
factors 63 70 465 472 O
within 71 77 473 479 O
3 78 79 480 481 B-upper_bound
months 80 86 482 488 I-upper_bound
prior 87 92 489 494 I-upper_bound
to 93 95 495 497 O
randomization 96 109 498 511 O

Histologically 0 14 512 526 O
confirmed 15 24 527 536 O
prostate 25 33 537 545 B-cancer
adenocarcinoma 34 48 546 560 I-cancer

Intercurrent 0 12 561 573 O
illness 13 20 574 581 O
that 21 25 582 586 O
is 26 28 587 589 O
not 29 32 590 593 O
controlled 33 43 594 604 O
such 44 48 605 609 O
as 49 51 610 612 O
active 52 58 613 619 B-chronic_disease
infection 59 68 620 629 I-chronic_disease
, 68 69 629 630 O
psychiatric 70 81 631 642 B-chronic_disease
illness 82 89 643 650 I-chronic_disease
/ 89 90 650 651 I-chronic_disease
social 90 96 651 657 I-chronic_disease
situations 97 107 658 668 I-chronic_disease
that 108 112 669 673 O
would 113 118 674 679 O
limit 119 124 680 685 O
compliance 125 135 686 696 O
with 136 140 697 701 O
study 141 146 702 707 O
requirements 147 159 708 720 O

Lesions 0 7 721 728 B-cancer
identified 8 18 729 739 O
on 19 21 740 742 O
other 22 27 743 748 O
imaging 28 35 749 756 B-treatment
modalities 36 46 757 767 I-treatment
( 47 48 768 769 O
e.g. 48 52 769 773 O
PSMA 53 57 774 778 B-treatment
or 58 60 779 781 O
choline 61 68 782 789 B-treatment
PET 69 72 790 793 I-treatment
) 72 73 793 794 O
that 74 78 795 799 O
are 79 82 800 803 O
not 83 86 804 807 O
visualized 87 97 808 818 O
on 98 100 819 821 O
CT 101 103 822 824 B-treatment
and/or 104 110 825 831 O
MRI 111 114 832 835 B-treatment
or 115 117 836 838 O
radionuclide 118 130 839 851 B-treatment
bone 131 135 852 856 I-treatment
scan 136 140 857 861 I-treatment

Medications 0 11 862 873 O
known 12 17 874 879 O
to 18 20 880 882 O
lower 21 26 883 888 O
the 27 30 889 892 O
seizure 31 38 893 900 O
threshold 39 48 901 910 O
must 49 53 911 915 O
be 54 56 916 918 O
discontinued 57 69 919 931 O
or 70 72 932 934 O
substituted 73 84 935 946 O
at 85 87 947 949 O
least 88 93 950 955 O
4 94 95 956 957 B-lower_bound
weeks 96 101 958 963 I-lower_bound
prior 102 107 964 969 I-lower_bound
to 108 110 970 972 O
cycle 111 116 973 978 O
1 117 118 979 980 O
day 119 122 981 984 O
1 123 124 985 986 O

Must 0 4 987 991 O
also 5 9 992 996 O
agree 10 15 997 1002 O
not 16 19 1003 1006 O
to 20 22 1007 1009 O
donate 23 29 1010 1016 O
sperm 30 35 1017 1022 O
during 36 42 1023 1029 O
the 43 46 1030 1033 O
study 47 52 1034 1039 O
and 53 56 1040 1043 O
for 57 60 1044 1047 O
3 61 62 1048 1049 B-upper_bound
months 63 69 1050 1056 I-upper_bound
after 70 75 1057 1062 O
receiving 76 85 1063 1072 O
the 86 89 1073 1076 O
last 90 94 1077 1081 O
dose 95 99 1082 1086 O
of 100 102 1087 1089 O
study 103 108 1090 1095 O
drug 109 113 1096 1100 O

No 0 2 1101 1103 O
definitive 3 13 1104 1114 O
evidence 14 22 1115 1123 O
of 23 25 1124 1126 O
metastases 26 36 1127 1137 B-cancer
on 37 39 1138 1140 O
screening 40 49 1141 1150 O
CT 50 52 1151 1153 B-treatment
or 53 55 1154 1156 O
MRI 56 59 1157 1160 B-treatment
of 60 62 1161 1163 I-treatment
abdomen 63 70 1164 1171 I-treatment
/ 70 71 1171 1172 I-treatment
pelvis 71 77 1172 1178 I-treatment
and 78 81 1179 1182 I-treatment
radionuclide 82 94 1183 1195 I-treatment
whole 95 100 1196 1201 I-treatment
body 101 105 1202 1206 I-treatment
bone 106 110 1207 1211 I-treatment
scan 111 115 1212 1216 I-treatment
per 116 119 1217 1220 O
the 120 123 1221 1224 O
judgment 124 132 1225 1233 O
of 133 135 1234 1236 O
the 136 139 1237 1240 O
investigator 140 152 1241 1253 O

Platelets 0 9 1254 1263 B-clinical_variable
≥ 10 11 1264 1265 O
100,000 12 19 1266 1273 B-lower_bound
/ 19 20 1273 1274 I-lower_bound
microliter 20 30 1274 1284 I-lower_bound
independent 31 42 1285 1296 O
of 43 45 1297 1299 O
transfusion 46 57 1300 1311 O
and/or 58 64 1312 1318 O
growth 65 71 1319 1325 O
factors 72 79 1326 1333 O
within 80 86 1334 1340 O
3 87 88 1341 1342 B-upper_bound
months 89 95 1343 1349 I-upper_bound
prior 96 101 1350 1355 I-upper_bound
to 102 104 1356 1358 O
randomization 105 118 1359 1372 O

Prior 0 5 1373 1378 B-treatment
ADT 6 9 1379 1382 I-treatment
and/or 10 16 1383 1389 O
first 17 22 1390 1395 B-treatment
generation 23 33 1396 1406 I-treatment
anti 34 38 1407 1411 I-treatment
- 38 39 1411 1412 I-treatment
androgen 39 47 1412 1420 I-treatment
in 48 50 1421 1423 I-treatment
the 51 54 1424 1427 I-treatment
( 55 56 1428 1429 I-treatment
neo)adjuvant 56 68 1429 1441 I-treatment
and/or 69 75 1442 1448 I-treatment
salvage 76 83 1449 1456 I-treatment
setting 84 91 1457 1464 I-treatment
before 92 98 1465 1471 O
, 98 99 1471 1472 O
during 100 106 1473 1479 O
, 106 107 1479 1480 O
and/or 108 114 1481 1487 O
following 115 124 1488 1497 O
radiation 125 134 1498 1507 B-treatment
or 135 137 1508 1510 O
surgery 138 145 1511 1518 B-treatment
is 146 148 1519 1521 O
allowed 149 156 1522 1529 O
provided 157 165 1530 1538 O
last 166 170 1539 1543 O
effective 171 180 1544 1553 O
dose 181 185 1554 1558 O
of 186 188 1559 1561 O
ADT 189 192 1562 1565 O
and/or 193 199 1566 1572 O
first 200 205 1573 1578 B-treatment
- 205 206 1578 1579 I-treatment
generation 206 216 1579 1589 I-treatment
anti 217 221 1590 1594 I-treatment
- 221 222 1594 1595 I-treatment
androgen 222 230 1595 1603 I-treatment
is 231 233 1604 1606 O
> 234 235 1607 1608 O
9 236 237 1609 1610 B-lower_bound
months 238 244 1611 1617 I-lower_bound
prior 245 250 1618 1623 I-lower_bound
to 251 253 1624 1626 O
date 254 258 1627 1631 O
of 259 261 1632 1634 O
randomization 262 275 1635 1648 O
and 276 279 1649 1652 O
total 280 285 1653 1658 B-clinical_variable
duration 286 294 1659 1667 I-clinical_variable
of 295 297 1668 1670 I-clinical_variable
prior 298 303 1671 1676 I-clinical_variable
therapy 304 311 1677 1684 I-clinical_variable
is 312 314 1685 1687 O
≤ 315 316 1688 1689 O
36 317 319 1690 1692 B-upper_bound
months 320 326 1693 1699 I-upper_bound

Prior 0 5 1700 1705 B-treatment
androgen 6 14 1706 1714 I-treatment
deprivation 15 26 1715 1726 I-treatment
therapy 27 34 1727 1734 I-treatment
and/or 35 41 1735 1741 O
first 42 47 1742 1747 O
generation 48 58 1748 1758 O
anti 59 63 1759 1763 O
- 63 64 1763 1764 O
androgen 64 72 1764 1772 O
( 73 74 1773 1774 O
e.g. 74 78 1774 1778 O
bicalutamide 79 91 1779 1791 B-treatment
, 91 92 1791 1792 O
nilutamide 93 103 1793 1803 B-treatment
, 103 104 1803 1804 O
flutamide 105 114 1805 1814 B-treatment
) 114 115 1814 1815 O
for 116 119 1816 1819 O
biochemically 120 133 1820 1833 O
recurrent 134 143 1834 1843 O
prostate 144 152 1844 1852 B-cancer
cancer 153 159 1853 1859 I-cancer

Prior 0 5 1860 1865 B-treatment
bilateral 6 15 1866 1875 I-treatment
orchiectomy 16 27 1876 1887 I-treatment

Prior 0 5 1888 1893 B-treatment
treatment 6 15 1894 1903 I-treatment
with 16 20 1904 1908 I-treatment
CYP17 21 26 1909 1914 I-treatment
inhibitor 27 36 1915 1924 I-treatment
( 37 38 1925 1926 O
e.g. 38 42 1926 1930 O
ketoconazole 43 55 1931 1943 B-treatment
, 55 56 1943 1944 O
abiraterone 57 68 1945 1956 B-treatment
acetate 69 76 1957 1964 I-treatment
, 76 77 1964 1965 O
galeterone 78 88 1966 1976 B-treatment
) 88 89 1976 1977 O
or 90 92 1978 1980 O
second 93 99 1981 1987 B-treatment
generation 100 110 1988 1998 I-treatment
androgen 111 119 1999 2007 I-treatment
receptor 120 128 2008 2016 I-treatment
antagonist 129 139 2017 2027 I-treatment
including 140 149 2028 2037 O
apalutamide 150 161 2038 2049 B-treatment
or 162 164 2050 2052 O
enzalutamide 165 177 2053 2065 B-treatment

Screening 0 9 2066 2075 O
serum 10 15 2076 2081 B-clinical_variable
testosterone 16 28 2082 2094 I-clinical_variable
> 29 30 2095 2096 O
150 31 34 2097 2100 B-lower_bound
ng 35 37 2101 2103 I-lower_bound
/ 37 38 2103 2104 I-lower_bound
dL 38 40 2104 2106 I-lower_bound

Seizure 0 7 2107 2114 B-chronic_disease
or 8 10 2115 2117 O
known 11 16 2118 2123 O
condition 17 26 2124 2133 O
that 27 31 2134 2138 O
may 32 35 2139 2142 O
pre 36 39 2143 2146 O
- 39 40 2146 2147 O
dispose 40 47 2147 2154 O
to 48 50 2155 2157 O
seizure 51 58 2158 2165 B-chronic_disease
( 59 60 2166 2167 O
e.g. 60 64 2167 2171 O
prior 65 70 2172 2177 O
stroke 71 77 2178 2184 B-chronic_disease
within 78 84 2185 2191 O
1year 85 90 2192 2197 B-upper_bound
to 91 93 2198 2200 O
randomization 94 107 2201 2214 O
, 107 108 2214 2215 O
brain 109 114 2216 2221 B-chronic_disease
arteriovenous 115 128 2222 2235 I-chronic_disease
malformation 129 141 2236 2248 I-chronic_disease
, 141 142 2248 2249 O
Schwannoma 143 153 2250 2260 B-cancer
, 153 154 2260 2261 O
meningioma 155 165 2262 2272 B-cancer
, 165 166 2272 2273 O
or 167 169 2274 2276 O
other 170 175 2277 2282 O
benign 176 182 2283 2289 O
CNS 183 186 2290 2293 B-cancer
or 187 189 2294 2296 I-cancer
meningeal 190 199 2297 2306 I-cancer
disease 200 207 2307 2314 I-cancer
which 208 213 2315 2320 O
may 214 217 2321 2324 O
require 218 225 2325 2332 O
treatment 226 235 2333 2342 O
with 236 240 2343 2347 O
surgery 241 248 2348 2355 B-treatment
or 249 251 2356 2358 O
radiation 252 261 2359 2368 B-treatment
therapy 262 269 2369 2376 I-treatment
) 269 270 2376 2377 O

Serum 0 5 2378 2383 B-clinical_variable
albumin 6 13 2384 2391 I-clinical_variable
≥ 14 15 2392 2393 O
3.0 16 19 2394 2397 B-lower_bound
g 20 21 2398 2399 I-lower_bound
/ 21 22 2399 2400 I-lower_bound
dL 22 24 2400 2402 I-lower_bound

Serum 0 5 2403 2408 B-clinical_variable
aspartate 6 15 2409 2418 I-clinical_variable
transaminase 16 28 2419 2431 I-clinical_variable
( 29 30 2432 2433 I-clinical_variable
AST 30 33 2433 2436 I-clinical_variable
; 33 34 2436 2437 O
serum 35 40 2438 2443 B-clinical_variable
glutamic 41 49 2444 2452 I-clinical_variable
oxaloacetic 50 61 2453 2464 I-clinical_variable
transaminase 62 74 2465 2477 I-clinical_variable
[ 75 76 2478 2479 I-clinical_variable
SGOT 76 80 2479 2483 I-clinical_variable
] 80 81 2483 2484 I-clinical_variable
) 81 82 2484 2485 O
and 83 86 2486 2489 O
serum 87 92 2490 2495 B-clinical_variable
alanine 93 100 2496 2503 I-clinical_variable
transaminase 101 113 2504 2516 I-clinical_variable
( 114 115 2517 2518 I-clinical_variable
ALT 115 118 2518 2521 I-clinical_variable
; 118 119 2521 2522 O
serum 120 125 2523 2528 B-clinical_variable
glutamic 126 134 2529 2537 I-clinical_variable
pyruvic 135 142 2538 2545 I-clinical_variable
transaminase 143 155 2546 2558 I-clinical_variable
[ 156 157 2559 2560 I-clinical_variable
SGPT 157 161 2560 2564 I-clinical_variable
] 161 162 2564 2565 I-clinical_variable
) 162 163 2565 2566 O
< 164 165 2567 2568 O
2.5 166 169 2569 2572 B-upper_bound
x 170 171 2573 2574 I-upper_bound
upper 172 177 2575 2580 I-upper_bound
limit 178 183 2581 2586 I-upper_bound
of 184 186 2587 2589 I-upper_bound
normal 187 193 2590 2596 I-upper_bound
( 194 195 2597 2598 I-upper_bound
ULN 195 198 2598 2601 I-upper_bound
) 198 199 2601 2602 I-upper_bound

Serum 0 5 2603 2608 B-clinical_variable
potassium 6 15 2609 2618 I-clinical_variable
≥ 16 17 2619 2620 O
3.5 18 21 2621 2624 B-lower_bound
mmol 22 26 2625 2629 I-lower_bound
/ 26 27 2629 2630 I-lower_bound
L 27 28 2630 2631 I-lower_bound

Uncontrolled 0 12 2632 2644 B-chronic_disease
hypertension 13 25 2645 2657 I-chronic_disease

Use 0 3 2658 2661 O
of 4 6 2662 2664 O
5 7 8 2665 2666 B-treatment
- 8 9 2666 2667 I-treatment
alpha 9 14 2667 2672 I-treatment
reductase 15 24 2673 2682 I-treatment
inhibitor 25 34 2683 2692 I-treatment
within 35 41 2693 2699 O
42 42 44 2700 2702 B-upper_bound
days 45 49 2703 2707 I-upper_bound
prior 50 55 2708 2713 I-upper_bound
to 56 58 2714 2716 O
cycle 59 64 2717 2722 O
1 65 66 2723 2724 O
day 67 70 2725 2728 O
1 71 72 2729 2730 O

Use 0 3 2731 2734 O
of 4 6 2735 2737 O
investigational 7 22 2738 2753 O
agent 23 28 2754 2759 O
within 29 35 2760 2766 O
28 36 38 2767 2769 B-upper_bound
days 39 43 2770 2774 I-upper_bound
prior 44 49 2775 2780 I-upper_bound
to 50 52 2781 2783 O
randomization 53 66 2784 2797 O

Use 0 3 2798 2801 O
of 4 6 2802 2804 O
other 7 12 2805 2810 O
prohibited 13 23 2811 2821 O
medications 24 35 2822 2833 O
within 36 42 2834 2840 O
7 43 44 2841 2842 B-upper_bound
days 45 49 2843 2847 I-upper_bound
prior 50 55 2848 2853 I-upper_bound
to 56 58 2854 2856 O
cycle 59 64 2857 2862 O
1 65 66 2863 2864 O
day 67 70 2865 2868 O
1 71 72 2869 2870 O
on 73 75 2871 2873 O
study 76 81 2874 2879 O
( 82 83 2880 2881 O
Arms 83 87 2881 2885 O
B 88 89 2886 2887 O
and 90 93 2888 2891 O
C 94 95 2892 2893 O
only 96 100 2894 2898 O
) 100 101 2898 2899 O

with 0 4 2900 2904 O
a 5 6 2905 2906 O
minimum 7 14 2907 2914 O
of 15 17 2915 2917 O
3 18 19 2918 2919 B-lower_bound
values 20 26 2920 2926 O
separated 27 36 2927 2936 O
by 37 39 2937 2939 O
at 40 42 2940 2942 O
least 43 48 2943 2948 O
2 49 50 2949 2950 B-upper_bound
weeks 51 56 2951 2956 I-upper_bound
apart 57 62 2957 2962 O

